1 February 2021
Linklaters advises Takeda on completed sale of TachoSil to Corza
Advising firms
Deal team
8 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Aisling Zarraga Lead | Linklaters | Partner | Mainstream Corporate | London |
| James Inglis Lead | Linklaters | Partner | Mainstream Corporate | London |
| Nicole Meyer | Linklaters | Senior associate | Mainstream Corporate | London |
| Meila Burgess | Linklaters | Associate | Mainstream Corporate | London |
| Marly Didizian | Linklaters | Partner | Commercial | London |
| Rich Jones | Linklaters | Senior associate | Commercial | London |
| Jonas Koponen | Linklaters | Partner | Antitrust & Foreign Investment | Brussels |
| Thomas McGrath | Linklaters | Partner | Antitrust & Foreign Investment | New York |
Stated terms
- Stated value
- EUR 350m (€350 million)
- What the figure measures
- Total transaction value
- Client
- TakedaSell-side
- Counterparties
- Corza Health, Inc (Buy-side)